![](https://i0.wp.com/www.torontohpbfellowship.com/wp-content/uploads/2020/01/Faiyaz_Notta_Steven_Gallinger.jpg?resize=300%2C169&ssl=1)
Dr. Faiyaz Notta, (L) scientist with the Princess Margaret Cancer Centre and Ontario Institute for Cancer Research (OICR), and Dr. Steven Gallinger, surgical oncologist at the Princess Margaret, led a team which identified a specific alteration that drives a very aggressive subtype of pancreatic cancer. (Photos: UHN)
https://www.nature.com/articles/s41588-019-0566-9